COVID-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval
Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty over whether a rollout could begin this year.